Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HCV]

H Tsujii1, M Yoshikawa, H Nakano

  • 1Department of Clinico-Laboratory Diagnostics, Nara Medical University, Kashihara.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) RNA quantification and genotyping are crucial for treatment. Lower HCV RNA levels correlate with better responses to interferon-alpha therapy in chronic hepatitis C patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives.

Biochemistry·1992
Same author

[Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver].

Nihon Geka Gakkai zasshi·1992
Same author

Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin.

Antimicrobial agents and chemotherapy·1992
Same author

Microencapsulated islets in agarose gel as bioartificial pancreas for discordant xenotransplantation.

Transplantation proceedings·1992
Same author

[The surgical treatment for the Stanford type A aortic dissection].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1992
Same author

Charcot-Marie-Tooth disease with diaphragmatic weakness.

Internal medicine (Tokyo, Japan)·1992

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) is a significant cause of chronic liver disease.
  • Accurate detection and quantification of HCV RNA are essential for patient management.
  • Understanding HCV genotypes aids in epidemiological studies and treatment strategies.

Purpose of the Study:

  • To report the prevalence of different HCV genotypes in a specific population.
  • To evaluate the utility of RT-PCR and DNA-probe methods for HCV detection and quantification.
  • To investigate the relationship between HCV RNA levels, genotypes, and response to interferon-alpha therapy.

Main Methods:

  • Reverse Transcription Polymerase Chain Reaction (RT-PCR) for HCV RNA detection and quantification.
  • RT-PCR with type-specific primers for HCV genotyping (Types I-IV).

Related Experiment Videos

  • Interferon-alpha (recombinant interferon alpha 2a) treatment regimen for chronic active hepatitis C patients.

    • Main Results:

    • HCV genotype II was the most prevalent (90.3%), followed by mixed type (II + IV) (2.2%), Type III (3.2%), and Type IV (3.2%). Type I was 1.0%.
    • Competitive RT-PCR allows for quantification of HCV RNA, while DNA-probe offers a simpler detection method.
    • Significantly lower HCV RNA titers were observed in both short-term and long-term responders compared to non-responders to interferon-alpha therapy.

    Conclusions:

    • RT-PCR is a valuable tool for HCV RNA quantification and genotyping.
    • HCV genotype distribution varies, with genotype II being dominant in this study.
    • Lower baseline HCV RNA levels are associated with a higher likelihood of successful interferon-alpha therapy response.